| P50 | author | Marianne Cegarra-Escolano | Q85800696 |
| P2093 | author name string | Emmanuel Benizri | |
| | Daniel Benchimol | |
| | Jean-Louis Bernard | |
| | Jean-Marc Bereder | |
| | Vincent Casanova | |
| | Mariangela Desantis | |
| | Amine M Rahili | |
| P2860 | cites work | Peritonectomy procedures | Q34316366 |
| | Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. | Q34543902 |
| | Comprehensive management of diffuse malignant peritoneal mesothelioma | Q36452199 |
| | Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures | Q36811662 |
| | Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q37090867 |
| | The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. | Q37252027 |
| | Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. | Q37812968 |
| | Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. | Q38675685 |
| | Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis | Q39745290 |
| | Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study | Q39928697 |
| | Selection of patients and staging of peritoneal surface malignancies | Q41132530 |
| | Impact of the hyperthermic intraperitoneal chemotherapy on the fluid-electrolytes changes and on the acid-base balance | Q42924756 |
| | Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. | Q43064315 |
| | Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 |
| | Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 |
| | Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy | Q44373010 |
| | "Natural history" of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy | Q46675616 |
| | Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis | Q46932131 |
| | Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy | Q46980082 |
| | Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. | Q51742663 |
| | Learning curve of combined modality treatment in peritoneal surface disease. | Q51980855 |
| | Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. | Q53877416 |
| | Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer | Q60629725 |
| | Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion | Q61794224 |
| | Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy | Q61848904 |
| | Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion | Q61848905 |
| | Dissection by electrocautery with a ball tip | Q72123183 |
| | Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique | Q73327596 |
| | Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures | Q79121171 |
| | Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 |
| | Peritonectomy procedures | Q79182991 |
| | Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer | Q80033156 |
| | Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center | Q80199761 |
| | Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q81484790 |
| | Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery | Q81508810 |
| | Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer | Q81800767 |
| | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival | Q82664343 |
| | Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures | Q84250370 |
| | Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis | Q84576420 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 37-48 | |
| P577 | publication date | 2014-10-16 | |
| P1433 | published in | Langenbeck's Archives of Surgery | Q635673 |
| P1476 | title | Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) | |
| P478 | volume | 400 | |